AU5398000A - Galenic formulations of argatroban for subcutaneous administration - Google Patents

Galenic formulations of argatroban for subcutaneous administration

Info

Publication number
AU5398000A
AU5398000A AU53980/00A AU5398000A AU5398000A AU 5398000 A AU5398000 A AU 5398000A AU 53980/00 A AU53980/00 A AU 53980/00A AU 5398000 A AU5398000 A AU 5398000A AU 5398000 A AU5398000 A AU 5398000A
Authority
AU
Australia
Prior art keywords
argatroban
subcutaneous administration
galenic formulations
galenic
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53980/00A
Inventor
Frederic Andre
Alain Cuine
Gareth Lewis
Benedicte Roger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU5398000A publication Critical patent/AU5398000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU53980/00A 1999-05-11 2000-05-09 Galenic formulations of argatroban for subcutaneous administration Abandoned AU5398000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9905974 1999-05-11
FR9905974A FR2793412B1 (en) 1999-05-11 1999-05-11 GALENIC ARGATROBAN FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION
PCT/EP2000/004881 WO2000067772A1 (en) 1999-05-11 2000-05-09 Galenic formulations of argatroban for subcutaneous administration

Publications (1)

Publication Number Publication Date
AU5398000A true AU5398000A (en) 2000-11-21

Family

ID=9545446

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53980/00A Abandoned AU5398000A (en) 1999-05-11 2000-05-09 Galenic formulations of argatroban for subcutaneous administration

Country Status (3)

Country Link
AU (1) AU5398000A (en)
FR (1) FR2793412B1 (en)
WO (1) WO2000067772A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915290B2 (en) * 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0621036B1 (en) * 1993-04-22 1999-03-17 Senju Pharmaceutical Co., Ltd. Aqueous compositions comprising argatroban and cyclodextrin or caffeine
FR2715566B1 (en) * 1994-02-03 1996-03-08 Synthelabo Concentrated aqueous solutions of argatroban.

Also Published As

Publication number Publication date
FR2793412A1 (en) 2000-11-17
FR2793412B1 (en) 2001-07-27
WO2000067772A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
AU762322C (en) Novel galenic formulations of meloxicam for oral administration
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AU1585601A (en) Transdermal administration of huperzine
AU2001231000A1 (en) Dry powder formulations of antihistamine for nasal administration
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
AU2331801A (en) Improved pharmaceutical compositions for poorly soluble drugs
AU1928501A (en) Formulations for pharmaceutical agents ionizable as free acids or free bases
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
AU1689999A (en) Medicinal composition for percutaneous administration
AU4328800A (en) Pharmaceutical formulation
AU2001284444A1 (en) Preparations for oral administration
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
AU6715600A (en) Pharmaceutical formulations
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU1068101A (en) Transdermal administration of reboxetine
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU4977300A (en) Pharmaceutical formulations
AU1385801A (en) Pharmaceutical formulations
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
AU6503399A (en) Drug delivery catheter
AU5398000A (en) Galenic formulations of argatroban for subcutaneous administration
AU3926000A (en) Methods and compositions for drug delivery
EP1143990A3 (en) Pharmaceutical compostions comprising peg-asparaginase for the treatment of hiv infections
AU3839900A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase